Company intelligence / Profile preview

Catalent

Somerset, New Jersey, United Statescatalent.com ↗

Ownership: Public · CTLT
Employees: ~18000
Development stage: Commercial

Overview

Catalent enables pharmaceutical and biotech companies to accelerate product development with advanced formulation/delivery solutions. It has supported over 40% of recent new drug approvals globally and operates more than two dozen sites worldwide. The company does not have its own clinical pipeline but plays a critical role in bringing partner products to market.

Therapeutic areas: Multiple
Modalities: Small molecules (oral solid dose, controlled release)Biologics (including mAbs)Gene therapiesCell therapiesSoftgels, injectables, inhaled dose forms
Industry: Drug Discovery Services

Partnerships

Major partnerships include collaborations with leading pharmaceutical companies such as Galapagos NV for CAR-T cell therapy manufacturing supportGB Sciences for cannabinoid-derived medicinesTriphase Accelerator for ADCsmany top global pharma/biotech firms as customers

Financials

Market cap: $11.5B
Total revenue: $1B
Enterprise value: $16.1B

Beyond the preview

Go deeper on Catalent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Catalent.

Explore the full profile